This advocacy agenda offers options for improving health and health care at the state level during the 2019 session. It includes state policy options to consider in 2019 regarding private insurance coverage, Medicaid, oral health coverage, health equity, prescription drugs, surprise medical bills, and health care value.
Not measuring and paying for equity risks worsening disparities and it is a key missed opportunity for reducing disparities. This issue brief describes actionable opportunities at the state and federal level to measure and pay for equity.
A Framework for Advancing Health Equity and Value: Policy Options for Reducing Health Inequities by Transforming Healthcare Delivery and Payment Systems
Families USA created the Health Equity Task Force for Delivery and Payment Transformation to bring together state and national health equity thought leaders to catalyze much-needed action to leverage health system transformation for the benefit of those whom the health system is leaving behind. Ensuring that people who are facing the biggest barriers to good health and high-quality health care are served well by the health care system will improve care for everyone.
The ongoing effort to transform health care in the United States is an important opportunity to address racial, ethnic, and other health inequities directly and deliberately. A central pillar in delivery system and payment reform is promoting evidence-based care: incentivizing treatments with strong evidence of success and appropriate value, and disincentivizing those that are not supported by a strong evidence base.
Blueprint for Health Care Advocacy: How Community Health Workers Are Driving Health Equity and Value in New Mexico
Across the health care system, there is tremendous interest and momentum in reforming the way health care is delivered and paid for in order to improve health care quality and outcomes and at the same time, reduce costs. These reform efforts create an enormous opportunity to improve resources, infrastructure, and incentives for interventions to meaningfully reduce racial and ethnic health disparities. Yet, if these reforms are not designed and implemented carefully, they could actually end up making these disparities worse.
This guide outlines model policies for states to consider to rein in drug prices in 2019 and beyond. Those discussed first most directly target drug prices and therefore are likely to have the greatest impact. This piece also cautions against prioritizing approaches to import drugs from Canada, as these policies are less likely to bring savings despite their public appeal.
Advancing Health Equity through System Transformation: Strengthening the Evidence Base to Achieve Health Equity
Learn more about: Families USA's new Center on Health Equity Action for System Transformation and our Evidence for Equity Initiative; Concrete examples of how underrepresentation in research harms certain populations; and the benefits of using comparative effectiveness research and patient-centered outcomes research as methods to strengthening the evidence base.
The Health Equity Task Force for Delivery and Payment Transformation’s Top 19 Recommendations for 2019 and Beyond.
It took Zoey Salsbury six years to get an incorrect diagnosis for her constant pelvic and joint pain.
The first time she mentioned her pain to her doctor, during her freshman year of high school, her pain was dismissed as “growing pains.” She remembers thinking, “Well this growing thing is absolute [garbage] if this is how it feels.”
There has been an important and ongoing effort over the past decade to address the manifest failures of our health care system by changing payment and provider organization to reward value and not volume. But transformation efforts largely ignore one of our system’s most fundamental problems: persistent, extensive, severe, and costly health and health care inequities based on race, ethnicity, and geography, among other factors.